“Rare Diseases: Regulatory and Study Design Considerations”
Date: 16th November, 2:00-3:30 GMT
John Scott (Deputy Director of the Division of Biostatistics in FDA's Center for Biologics Evaluation and Research)
U.S. regulatory considerations and case studies for rare diseases
Lisa Hampson (Lecturer in Statistics, Lancaster University)
Bayesian methods for the design and interpretation of clinical trials in rare diseases
The webinar is free to attend. See abstracts and to register.